tiprankstipranks
Cardinal Health (CH:CLH)
NYSE:CLH
Switzerland Market

Cardinal Health (CLH) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

CLH Analyst Ratings

Strong Buy
12Ratings
Strong Buy
11 Buy
1 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Cardinal
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CLH Stock 12 Month Forecast

Average Price Target

$199.65
Based on 12 Wall Street analysts offering 12 month price targets for Cardinal Health in the last 3 months. The average price target is $199.65 with a high forecast of $209.39 and a low forecast of $174.49. The average price target represents a change from the last price of .
eyJuYXZpZ2F0b3IiOnsiZGlzYWJsZWQiOnRydWV9LCJleHBvcnRpbmciOnsiZW5hYmxlZCI6ZmFsc2V9LCJ0aXRsZSI6eyJ0ZXh0IjpudWxsfSwiY2hhcnQiOnsiaGVpZ2h0IjoyMDAsInN0eWxlIjp7ImZvbnRGYW1pbHkiOiJSb2JvdG8gRmxleCwgLWFwcGxlLXN5c3RlbSwgQmxpbmtNYWNTeXN0ZW1Gb250LCBTZWdvZSBVSSwgUm9ib3RvLCBIZWx2ZXRpY2EsIEFyaWFsLCBzYW5zLXNlcmlmLCBBcHBsZSBDb2xvciBFbW9qaSwgU2Vnb2UgVUkgRW1vamksIFNlZ29lIFVJIFN5bWJvbCIsImZvbnRXZWlnaHQiOiI0MDAiLCJjb2xvciI6IiM1ZDVkNWUifX0sInlBeGlzIjp7ImxhYmVscyI6eyJzdHlsZSI6eyJjb2xvciI6ImluaGVyaXQifX0sInZpc2libGUiOmZhbHNlfSwicGxvdE9wdGlvbnMiOnsic2VyaWVzIjp7InN0YXRlcyI6eyJpbmFjdGl2ZSI6eyJvcGFjaXR5IjoxfX19fSwieEF4aXMiOnsibGFiZWxzIjp7InN0eWxlIjp7ImNvbG9yIjoiaW5oZXJpdCJ9fSwidmlzaWJsZSI6ZmFsc2V9LCJsZWdlbmQiOnsic3ltYm9sUmFkaXVzIjowLCJzeW1ib2xQYWRkaW5nIjo0LCJzeW1ib2xIZWlnaHQiOjE0LCJib3JkZXJXaWR0aCI6MCwic3ltYm9sV2lkdGgiOjE0LCJhbGlnbiI6ImxlZnQiLCJ2ZXJ0aWNhbEFsaWduIjoiYm90dG9tIiwiZW5hYmxlZCI6ZmFsc2V9LCJ0b29sdGlwIjp7ImJhY2tncm91bmRDb2xvciI6IndoaXRlIn0sImNyZWRpdHMiOnsiZW5hYmxlZCI6ZmFsc2V9LCJhY2Nlc3NpYmlsaXR5Ijp7ImRlc2NyaXB0aW9uIjoiIn0sInNlcmllcyI6W3sidHlwZSI6ImFyZWEiLCJkYXRhIjpbXX1dfQ==
Highest Price Target$209.39Average Price Target$199.65Lowest Price Target$174.49
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William O'Neil Analyst forecast on CH:CLH
Unknown Analyst
William O'Neil
Not Ranked
William O'Neil
Buy
Initiated
06/12/26
Cardinal Health (CAH) Gets a Buy from William O'Neil
Barclays
CHF209.39
Buy
Reiterated
06/10/26
Barclays Keeps Their Buy Rating on Cardinal Health (CAH)
Bank of America Securities Analyst forecast on CH:CLH
Bank of America Securities
Bank of America Securities
CHF194.78
Buy
Reiterated
05/13/26
Analysts Conflicted on These Healthcare Names: Cardinal Health (NYSE: CAH), Baxter International (NYSE: BAX) and Cigna (NYSE: CI)
Morgan Stanley Analyst forecast on CH:CLH
Morgan Stanley
Morgan Stanley
CHF206.96
Buy
Reiterated
05/05/26
Cardinal Health (CAH) Gets a Buy from Morgan Stanley
Argus Research Analyst forecast on CH:CLH
Argus Research
Argus Research
CHF201.28
Buy
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH) and Dexcom (NASDAQ: DXCM)
J.P. Morgan Analyst forecast on CH:CLH
J.P. Morgan
J.P. Morgan
CHF197.22CHF174.49
Hold
Assigned
05/04/26
Cardinal Health price target lowered to $215 from $243 at JPMorganCardinal Health price target lowered to $215 from $243 at JPMorgan
Robert W. Baird Analyst forecast on CH:CLH
Robert W. Baird
Robert W. Baird
CHF208.58CHF201.28
Buy
Reiterated
05/01/26
Cardinal Health price target lowered to $248 from $257 at BairdCardinal Health price target lowered to $248 from $257 at Baird
TD Cowen
CHF203.71CHF206.96
Buy
Assigned
05/01/26
Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and Cardinal Health (NYSE: CAH)
Citi
CHF202.09CHF198.84
Buy
Assigned
05/01/26
Cardinal Health price target lowered to $245 from $249 at CitiCardinal Health price target lowered to $245 from $249 at Citi
Evercore ISI
CHF194.78
Buy
Reiterated
05/01/26
Evercore ISI Remains a Buy on Cardinal Health (CAH)
William Blair Analyst forecast on CH:CLH
William Blair
William Blair
Buy
Initiated
04/28/26
Cardinal Health Earns Buy Rating on High-Margin Growth Segments and Double-Digit EPS Outlook
Wells Fargo Analyst forecast on CH:CLH
Wells Fargo
Wells Fargo
CHF207.77
Buy
Assigned
04/13/26
Wells Fargo Gives a Buy Rating to Cardinal Health (CAH)
Deutsche Bank  Analyst forecast on CH:CLH
Deutsche Bank
Deutsche Bank
Hold
Reiterated
02/20/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Mizuho Securities Analyst forecast on CH:CLH
Mizuho Securities
Mizuho Securities
CHF190.73
Buy
Reiterated
02/10/26
Mizuho Securities Keeps Their Buy Rating on Cardinal Health (CAH)
UBS
CHF202.9CHF211.02
Buy
Reiterated
02/06/26
Cardinal Health price target raised to $260 from $250 at UBSCardinal Health price target raised to $260 from $250 at UBS
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William O'Neil Analyst forecast on CH:CLH
Unknown Analyst
William O'Neil
Not Ranked
William O'Neil
Buy
Initiated
06/12/26
Cardinal Health (CAH) Gets a Buy from William O'Neil
Barclays
CHF209.39
Buy
Reiterated
06/10/26
Barclays Keeps Their Buy Rating on Cardinal Health (CAH)
Bank of America Securities Analyst forecast on CH:CLH
Bank of America Securities
Bank of America Securities
CHF194.78
Buy
Reiterated
05/13/26
Analysts Conflicted on These Healthcare Names: Cardinal Health (NYSE: CAH), Baxter International (NYSE: BAX) and Cigna (NYSE: CI)
Morgan Stanley Analyst forecast on CH:CLH
Morgan Stanley
Morgan Stanley
CHF206.96
Buy
Reiterated
05/05/26
Cardinal Health (CAH) Gets a Buy from Morgan Stanley
Argus Research Analyst forecast on CH:CLH
Argus Research
Argus Research
CHF201.28
Buy
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH) and Dexcom (NASDAQ: DXCM)
J.P. Morgan Analyst forecast on CH:CLH
J.P. Morgan
J.P. Morgan
CHF197.22CHF174.49
Hold
Assigned
05/04/26
Cardinal Health price target lowered to $215 from $243 at JPMorganCardinal Health price target lowered to $215 from $243 at JPMorgan
Robert W. Baird Analyst forecast on CH:CLH
Robert W. Baird
Robert W. Baird
CHF208.58CHF201.28
Buy
Reiterated
05/01/26
Cardinal Health price target lowered to $248 from $257 at BairdCardinal Health price target lowered to $248 from $257 at Baird
TD Cowen
CHF203.71CHF206.96
Buy
Assigned
05/01/26
Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and Cardinal Health (NYSE: CAH)
Citi
CHF202.09CHF198.84
Buy
Assigned
05/01/26
Cardinal Health price target lowered to $245 from $249 at CitiCardinal Health price target lowered to $245 from $249 at Citi
Evercore ISI
CHF194.78
Buy
Reiterated
05/01/26
Evercore ISI Remains a Buy on Cardinal Health (CAH)
William Blair Analyst forecast on CH:CLH
William Blair
William Blair
Buy
Initiated
04/28/26
Cardinal Health Earns Buy Rating on High-Margin Growth Segments and Double-Digit EPS Outlook
Wells Fargo Analyst forecast on CH:CLH
Wells Fargo
Wells Fargo
CHF207.77
Buy
Assigned
04/13/26
Wells Fargo Gives a Buy Rating to Cardinal Health (CAH)
Deutsche Bank  Analyst forecast on CH:CLH
Deutsche Bank
Deutsche Bank
Hold
Reiterated
02/20/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Mizuho Securities Analyst forecast on CH:CLH
Mizuho Securities
Mizuho Securities
CHF190.73
Buy
Reiterated
02/10/26
Mizuho Securities Keeps Their Buy Rating on Cardinal Health (CAH)
UBS
CHF202.9CHF211.02
Buy
Reiterated
02/06/26
Cardinal Health price target raised to $260 from $250 at UBSCardinal Health price target raised to $260 from $250 at UBS
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cardinal Health

3 Months
Eric ColdwellRobert W. Baird
Success Rate
20/27 ratings generated profit
74%
Average Return
+6.38%
Copying Eric Coldwell's trades and holding each position for 3 Months would result in 74.07% of your transactions generating a profit, with an average return of +6.38% per trade.
1 Year
Success Rate
18/18 ratings generated profit
100%
Average Return
+30.79%
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +30.79% per trade.
2 Years
Success Rate
18/18 ratings generated profit
100%
Average Return
+75.33%
Copying Kevin Caliendo's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +75.33% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CLH Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
24
23
17
13
14
Hold
2
2
2
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
26
25
19
14
15
In the current month, CLH has received 14 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CLH average Analyst price target in the past 3 months is 199.65.
Each month's total comprises the sum of three months' worth of ratings.

CLH Financial Forecast

CLH Earnings Forecast

Next quarter’s earnings estimate for CLH is $1.93 with a range of $1.88 to $1.96. The previous quarter’s EPS was $2.53. CLH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.
Next quarter’s earnings estimate for CLH is $1.93 with a range of $1.88 to $1.96. The previous quarter’s EPS was $2.53. CLH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.

CLH Sales Forecast

Next quarter’s sales forecast for CLH is $52.13B with a range of $51.20B to $53.63B. The previous quarter’s sales results were $48.71B. CLH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.
Next quarter’s sales forecast for CLH is $52.13B with a range of $51.20B to $53.63B. The previous quarter’s sales results were $48.71B. CLH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.

CLH Stock Forecast FAQ

What is CH:CLH’s average 12-month price target, according to analysts?
Based on analyst ratings, Cardinal Health’s 12-month average price target is 199.65.
    What is CH:CLH’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:CLH, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Cardinal Health a Buy, Sell or Hold?
        Cardinal Health has a consensus rating of Strong Buy, which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Cardinal Health’s share price target?
          The average share price target for Cardinal Health is 199.65. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $209.39 ,and the lowest forecast is $174.49. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Cardinal Health?
            Cardinal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
              How can I buy shares of Cardinal Health?
              To buy shares of CH:CLH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.